NewsRx

Search our medical news database

Diabetes

Biosensor company completes successful in-vitro proof-of-concept studies

Published in Obesity and Diabetes Week, October 20th, 2003

M-Biotech, Inc., a developer of implantable glucose monitors and Hydrogel- based biosensors, announced that recent successful animal studies conducted by the company show proof-of-concept in animals for the company's continuous glucose monitor implant.

M-Biotech President and CEO In Suk Han, PhD, said, "This milestone brings us one step closer to the goal of developing a critically needed innovative way of monitoring the glucose levels of diabetes patients to improve their quality of life."

He continued: "We look forward to accelerating the development of this innovative medical device upon completion of our next round of financing."

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook